Kohlberg recaps CRO Worldwide Clinical Trials
TJC, which has been Worldwide’s sole investor since 2007, retains a meaningful minority equity stake in the CRO.
Nearly there!
A verification email is on its way to you. Please check your spam or junk folder just in case.
If you do not receive this within five minutes, please try to sign in again. If the problem persists, please email: subscriptions@pei.group .-
Sign in or Register
-
Issues with signing in? Click here
Don't have an account? Register now
-
